---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "ildfVVQlr3b+ngCPVQ+LEiqF2qciHpUIRyTK2Y+nCe1fy7OWng2cyLLLlPhFxuz/uuRKDkhKDEHegxB5eqgVe4uCSzF67ulOKECo2I3FzzUhXc+f22wci9F8n5zD/82RW/ghdRSW+1Mw3GSMxg+mwWRT/8yNtP8i7bygPgVU+z1Vp9sAd5cFWKZ4To4E9fHSRlq9Bui/84MMcvdKGQEuDOjV3VoZrsI6il7DLrLosG6fx7omMHhAokN5idVx5Eja42i8SHK5DAG2AqPASeKVf6MJUz/h19OZ9m+lxDASKRvVXQ/cCdKXGUavXNRefFshRKIa/IALehBlRpkDHbI/3CjjIalpdeQKqP2uPGx3AO0=;AxKi1H9hhskVOvUYtbHoaw=="
---

